We are live on ! Find out more
AC

Adelphi Capital Portfolio holdings

AUM $3.21M
1-Year Est. Return 121.6%
This Fund
S&P 500
This Quarter Est. Return
+32.44%
1 Year Est. Return
+121.6%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$483M
AUM Growth
+$296M
Cap. Flow
+$218M
Cap. Flow %
45.07%
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
2
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
TAK icon
Takeda Pharmaceutical
TAK
+$187M
2
WP
Worldpay, Inc.
WP
+$18M
3
RYAAY icon
Ryanair
RYAAY
+$13M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 39.13%
2 Industrials 12.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WP
1
DELISTED
Worldpay, Inc.
WP
$234M 48.59%
2,065,896
+198,293
+11% +$18M
TAK icon
2
Takeda Pharmaceutical
TAK
$55.9B
$189M 39.13%
+9,270,535
New +$187M
RYAAY icon
3
Ryanair
RYAAY
$30.1B
$59.3M 12.28%
1,977,313
+447,435
+29% +$13M

Similar funds

TA
TA Associates Boston, Massachusetts $4.01M AUM 59.82% 1-Year Est. Return
TAM
Trikon Asset Management Hong Kong $1.84M AUM 172.11% 1-Year Est. Return
TMC
TVL Management Corporation Menlo Park, California $1.84M AUM 0.1% 1-Year Est. Return
AV
Arboretum Ventures Ann Arbor, Michigan $1.72M AUM 82.7% 1-Year Est. Return
MVPI
Maven Ventures Partners II Palo Alto, California $958K AUM 41.74% 1-Year Est. Return
RIA
RP Investment Advisors Toronto, Ontario, Canada $900K AUM 17.98% 1-Year Est. Return
IAC
ION Acquisition Corp Herzliya, Israel $5.63M AUM 38.71% 1-Year Est. Return
ALBM
Alcentra Ltd (BNY Mellon) London, United Kingdom $566K AUM 51.56% 1-Year Est. Return

Adelphi Capital's Q1 2019 Portfolio in Review

As of Q1 2019, Adelphi Capital held 3 positions worth $483M, up 159% from $186M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Adelphi Capital deployed $218M of net new capital in Q1 2019, opening 1 new position and adding to 2 existing holdings. Its largest new stake was Takeda Pharmaceutical: 9,270,535 shares worth $189M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, followed by Industrials.

  • Adelphi Capital's largest Q1 2019 buy was Takeda Pharmaceutical: 9,270,535 shares worth $189M.
  • Adelphi Capital added most to Worldpay, Inc. in Q1 2019, an estimated $18M increase.
  • Adelphi Capital's ten largest holdings make up 100% of its $483M portfolio in Q1 2019.
  • Adelphi Capital opened 1 new position and closed 0 in Q1 2019.
  • Adelphi Capital's portfolio value rose 159% quarter-over-quarter to $483M.

Based on Adelphi Capital's 13F filing for Q1 2019, filed 7 May 2019.